ANTIBIOTIC SUSCEPTIBILITY OF COMMUNITY-ACQUIRED STAPHYLOCOCCUS AUREUS

Similar documents
CHAPTER 1 INTRODUCTION

Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards

Int.J.Curr.Microbiol.App.Sci (2016) 5(12):

Staphylococcus aureus

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

Antimicrobial Resistance

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING

Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital

Methicillin-Resistant Staphylococcus aureus

Doxycycline staph aureus

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018

Staphylococcus aureus nasal carriage in diabetic patients in a tertiary care hospital

Isolation of MRSA from the Oral Cavity of Companion Dogs

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ

Nature and Science, 5(3), 2007, Olowe, Eniola, Olowe, Olayemi. Antimicrobial Susceptibility and Betalactamase detection of MRSA in Osogbo.

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

BMR Microbiology. Research Article

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

RCH antibiotic susceptibility data

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

Prevalence & Risk Factors For MRSA. For Vets

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Antimicrobial Resistance and Prescribing

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

Post-operative surgical wound infection

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Mrsa abscess and cellulitis

Ophthalmology Research: An International Journal 2(6): , 2014, Article no. OR SCIENCEDOMAIN international

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

ORIGINAL ARTICLE. Methicillin-Resistant Staphylococcus aureus Otorrhea After Tympanostomy Tube Placement

CHAPTER 18 THE COCCI OF MEDICAL IMPORTANCE. Learning Objectives

The Changing Epidemiology of Staphylococcus aureus?

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Tel: Fax:

Geoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Prevalence and Antibiogram of Penicillinase-Producing Staphylococcus aureus among Nigerian Studen

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

Resistance to cloxacillin among hospital staphylococci.

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article

NASAL COLONIZATION WITH STAPHYLOCOCCUS AUREUS IN BASRA MEDICAL AND DENTISTRY STUDENTS

MRSA surveillance 2014: Poultry

VLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Antimicrobial susceptibility

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.

WHY IS THIS IMPORTANT?

Methicillin and Clindamycin resistance in biofilm producing staphylococcus aureus isolated from clinical specimens

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10

Gram-positive cocci Staphylococci and Streptococcia

Methicillin-resistant Staphylococcus aureus (MRSA) on Belgian pig farms

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates

Cipro for gram positive cocci in urine

Risk factors? Insect bites? Hygiene? Household crowding Health literacy

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Principles of Antimicrobial Therapy

ARCH-Vet. Summary 2013

Acquisition of antibiotic resistance by

Bacterial whole genome sequencing in clinical microbiology, infection control and public health. Julian Parkhill. FIS, Birmingham, November 2013

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Antibiotic susceptibility of Staphylococcus aureus in suppurative lesions in Lacor Hospital, Uganda

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN

Original article DOI: Journal of International Medicine and Dentistry 2016; 3(3):

Methicillin resistant Staphylococcus aureus : a multicentre study

CONTAGIOUS COMMENTS Department of Epidemiology

Mechanism of antibiotic resistance

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Int.J.Curr.Microbiol.App.Sci (2018) 7(1):

Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"

Determination of antibiotic sensitivities by the

Int.J.Curr.Microbiol.App.Sci (2015) 4(9):

Multi-drug resistant microorganisms

Summary of the latest data on antibiotic resistance in the European Union

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

22/09/2010. Laboratory 2a + b Staphylococci and Streptococci

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Prevalence and Drug Resistance Patterns of Staphylococcus Aureus in Lactating Dairy Cow s Milk in Wolayta Sodo, Ethiopia

Transcription:

Med. J. Malaysia Vol. 41 No. 1 March 1986 ANTIBIOTIC SUSCEPTIBILITY OF COMMUNITY-ACQUIRED STAPHYLOCOCCUS AUREUS TAN HENG SOON NGEOW YUN FaNG FARIDA JAMAL SUMMARY 55% of a sample of patients in a rural community, and 76% of a sample of patients and staff in the local district hospital were found to be nasal carriers for Staphylococcus aureus. The in vitro antibiotic susceptibility patterns of 46 strains of S. aureus isolated in nasal carriers as well as of 43 strains in community-acquired skin infections were characterised. High levels of resistance were expressed to penicillin (73%), cephalexin (64%) and tetracycline (46%). Resistance to erythromycin (18%) was moderate. A few strains showed resistance to methicillin (5 isolates), vancomycin (4), [usidic acid (3), cotrimoxazole (1), and none to gentamicin. Penicillin can no longer be recommended for treating community-acquired S. aureus infections. INTRODUCTION Staphylococcus aureus remains an important pathogen in the community and the hospital. In 1980 82, nosocomial infection surveillance was conducted by. the Centers for Disease Control in the United States; 5% of hospitalized patients developed nosocomial infections which contributed directly or indirectly to 5% of deaths." S. eureus, after E. coli, was the second most common nosocomial pathogen, accounting for 11% of such infections. It was the leading cause in the following categories: 35% of cutaneous infections, 17% of surgical wound infections and 13% of primary bacteremia. It is not only the incidence of S. aureus infections that is worrisome, but the emergence of multiple-resistant str ains.? Tan Heng Soon, MD Department of Medicine Ngeow Yun Fong, MBBS, MSc Department of Medical Microbiology Faculty of Medicine University of Malaya 59100 Kuala Lumpur, Malaysia Farida Jamal, MBBS, MSc, MRCPath Department of Medical Microbiology Faculty of Medicine Universiti Kebangsaan Malaysia 50300 Kuala Lumpur, Malaysia The introduction of penicillin in the 40's was rapidly followed by the appearance of betalactarnase producing S. aureus. Beta-Iactamase resistant semi-synthetic penicillins, as typified by methicillin, were introduced in 1959 to overcome this problem. Within a decade however, in the United Kingdom and Europe, methicillin-resistant S. aureus (MRSA) multiplied to epidemic proportions (in places up to 30% of strains were MRSA) before levelling off? Two decades later, the initially low incidence of MRSA in the United States is now rising. 2 In the period 1980-82 under surveillance, the incidence of MRSA rose from 2% to 9%, chiefly in the large teaching hospitals 24

which individually reported up to 18% MRSA strains among their isolates.' Methicillin-resistant S. aureus is particularly alarming because it is usually associated with multiple resistance to other antibiotics like aminoglycoside, chloramphenicol, erythromycin and tetracvcline." These multiple-resistant S. aureus are mainly associated with nosocomial infections. Staphylococcal infections acquired in the community are usually considered to be still sensitive to penicillin. However, reports from the United States show that this is no longer true." Furthermore, in some areas, MRSA has become prevalent in the community; for instance, among drug addicts.",7 We undertook this survey of nasal carriage and a study of community-acquired S. aureus skin infection to determine the antibiotic susceptibility and prevalence of multiple-resistant S. aureus in the community. METHODS Nasal carriage This study was carried out in the rural district hospital of Banting, Selangor. Swabs were taken from the anterior nares of 36 unselected outpatients and 34 unselected inpatients and hospital staff who had not taken any antibiotics in the preceding two weeks. Impetigo infection This part of the study was carried out on 60 patients in an urban clinic in Sentul, Kuala Lumpur and 33 patients in the rural outpatient clinic of Banting Hospital. Swabs were taken from active impetiginous skin lesions and transported to the laboratory in Stuarts transport media. Microbiology Identification of S. aureus was made on the basis of morphologic characteristics of the colony on 10% sodium chloride agar plates, Gram stain and a positive tube coagulase test. Antibiotic sensitivity was tested by the comparative disc method 8 using Oxford Staphylococcus NCTC 6571 as control. Methicillin resistance was tested by incubating inoculated nutrient agar plates at 30 C for 18-24 hours." Statistical analysis Variance between cases was analysed using chi-square and Fisher's exact test. RESULTS 55% of outpatients and 76% of hospital staff and patients carried S. aureus in their anterior nares (Table 11). Transient and chronic nasal carriers were not differentiated. 76% of all S. eureus isolates in nasal carriage were penicillin-resistant (Table 11). S. aureus from outpatients was just as likely as those from hospital staff and patients to be penicillin-resistant. In all the carriers, multiple resistances to cephalexin (70%) and tetracycline (33%) were present. An occasional isolate was resistant to eryth ro- TABLE I NASAL CARRIAGE OF S. AUREUS AT A RURAL DISTRICT HOSPITAL Clinic n = 36 Hospital n = 34 Total n = 70 p value No. % No. % No. % Staphylococcus sp. S. aureus 26 20 55 34 26 76 60 46 68 NS NS = not significant; P value> 0.1 0; Beta value> 0.1 O. 25

mycin (15%), fusidic acid (two isolates) and vancomycin (one isolate). No resistance to gentamicin and cotrimoxazole was recorded. Four isolates of S. aureus from outpatients and only one hospital isolate were methicillin-resistant. Overall, the antibiotic susceptibility of S. aureus in nasal carriage was similar in the community and within the district hospital. A similar pattern was found in S. aureus isolated from skin impetigo acquired in the community (Table Ill). 70% of the S. aureus were penicillin-resistant. Associated antibiotic resistances were again expressed to cephalexin (52%), and tetracycline (60%). Some isolates were resistant to erythromycin (21 %), and occasional ones to fusidic acid (one isolate), vancomycin (three), and cotrimoxazole (one). In this group, no resistance to gentamicin or methicillin was recorded. Interestingly, no differences were detected in the antibiotic susceptibility pattern between the isolates from an urban (Sentu I) and a rural (Banting) community. DISCUSSION S. aureus is a facultative aerobic, gram-positive coccus; it is pathogenic to man by virtue of its production of enzymes like lipase, hyaluronidase, DNAse, coagulase, as well as cell wall Protein A and extracellular capsule which accounts for its invasiveness, resilient survival within polymorphonuclear leucocytes and tendency to abscess formation."? S. aureus found in nasal carriage is a useful and valid source for studying and monitoring the prevalence of antibiotic' susceptibility patterns because the nose is the main reservoir of pyogenic Staphylococcus. Wound infections often originate directly or indirectly from nasal strains. The phage type of S. aureus found in infected lesions have been found to correspond in general with those found in the patients' nares. I I Furthermore, they share the same virulence.l? d 3 The nasal carriage of S. aureus in this study was 55-76%, with no significant difference (p value> 0.10) between community and hospitalrelated carriers. This is comparable to most studies which report 40-60% nasal carriage in the community, although hospital rates are usually siightly higher around 60-80%.13 -IS Almost all S. aureus are lysogenic, and many TABLE 11 ANTIBIOTIC RESISTANCE PATTERN OF S. AUREUS IN NASAL CARRIERS AT A RURAL DISTRICT HOSPITAL Antibiotics Clinic Hospital Total n ; 36 n ; 26 n ; 46 p value No. % No. % No. % Penicillin 14 70 21 81 35 76 NS Methicillin 4 20 1 4 5 11 NS Cephalexin 12 60 20 77 32 70 NS Tetracycline 3 15 12 46 15 33 NS Erythromycin 4 20 3 12 7 15 NS Gentamicin 0 0 0 0 0 0 Vancomycin 0 0 1 4 1 2 Fusidic acid 2 10 0 0 2 4 Cotrimoxazole 0 0 0 0 0 0 NS ; not significant; p value> 0.05. 26

TABLE III IIl..R-rIR1I"lIlR,I"'-rII_ RESISTANCE PATTERN OF S. AUREUS ISOLATED FROM IMPETIGINOUS SKIN LESIONS ACQUIRED IN URBAN (SENTUL) AND RURAL (BANTING) COMMUNITY Antibiotics Sentul Banting Total n = 20 n = 23 n = 43 No. % No. % No. % p value Penicillin 16 80 14 61 30 70 NS Methicillin 0 0 0 0 0 0 NS Cephalexin NA 12 52 NA Tetracycline 11 55 15 65 26 60 NS Erythromycin 2 10 7 30 9 21 NS Gentamicin NA 0 0 NA Vancomycin NA 3 13 NA Fusidic acid 0 0 1 4 1 2 Cotrimoxazole 0 0 1 4 1 2 NA = not available; NS = not significant; p value> 0.05. contain inducible beta-iactamase coded on nonconjugative plasmids which are transductible. 1 6, 1 7 In the first decade following the introduction of penicillin, penicillin-resistant S. aureus was isolated only in hospital-related infections.v" However, by the 70's, up to 80% of S. aureus in the community were reported to be penicillin-resistant." In the present study, 70-76% of the S. aureus isolated in the community were penicillin-resistant regardless of whether they were involved in active infections or by nasal carriage. Such high rates of beta-iactamase production in S. aureus may reflect the selection pressure from the general and indiscriminate use of beta-iactam antibiotics in both rural and urban communities. Given such high rates of penicillin-resistant S. aureus, it is no longer tenable to treat any acute community-acquired infection of S. aureus requiring antibiotics with penicillin (including ampicillin). Neither is cephalexin nor tetracycline recommended for that matter (Tables 1I and Ill). Erythromycin or cotrimoxazole may be more appropriate for such infections. The phenomenon of methicillin resistance, on the other hand, is neither related to plasmid trans- mission nor to enzyme inactivation. It may represent a chromosomal mutation affecting cell wall permeability or receptor binding to the drug. 1 9 Recently isolated MRSA strains are just as virulent as penicillin-sensitive S. aureus 4, 2 0-2 2 The dangers of transmission of M RSA is further compounded by the additional association with resistance to multiple antibiotics." The MRSA isolates found in this study were indeed consistently associated with antibiotic resistance to cephalosporin, and erythromycin or fusidic acid. additionally to tetracycline or Methicillin-resistant S. aureus has already made inroads in this country. A survey of nosocomial infections in the General Hospital, Kuala Lumpur in 1982 revealed that 250/0 of the S. aureus isolated were methicillin-resistant.f " Fortunately, in the present study, none of the community-acquired infections was caused by M RSA. Interestingly, four nasal carriers in the rural community carried MRSA. Methicillin resistance in S. aureus can be naturally occurring, but is rare. 2 However with the widespread use of beta- 27

lactam antibiotics in general, M RSA is selected out because these strains always produce betalactamase in large amounts. A carrier state could then occur through exposure to previous infection treated with beta-iactam antibiotics. While nasal carriage of S. aureus forms one of the reservoir habitats for the continued maintenance of recurrent S. aureus infections, carrier rates of MRSA are generally low because MRSA strains exhibit lower adherance to the nasal rnucosa.f " In the treatment of serious infections caused by MRSA, vancomycin is the drug of choice." s,2 6 From this perspective, the presence of even a few isolates of S. aureus in this study exhibiting resistance to vancomycin (Tables 1I and Ill) should be viewed with concern. Periodic surveillance to determine the prevalence of this pattern should be maintained. Even after treatment with vancomycin for M RSA infections, patients may remain as nasal carriers. Nasal carriers need not be treated unless they are a source of recurrent infections to themselves or to other patients.? S.27 Intranasal application of bacitracin ointment is ineffective." 8 When treatment is necessary, oral rifampicin may be given together with vancomycin or cotrirnoxazote.? S,29,30 CONCLUSION In this study, the nasal carriage rate for S. aureus in a rural community was found to be almost as high as in the local district hospital. Penicillin resistance was widespread in S. aureus isolated in both the urban and rural community and in the rural district hospital. This was associated with multiple antibiotic resistances to cephalosporin, tetracycline, and to a smaller extent, to erythromycin as well. Although only a few isolates of S. aureus from the community expressed resistance to methicillin, and to vancomycin, surveillance needs to be continued to monitor their prevalance. Based on the in vitro antibiogram of S. aureus, the treatment of acute, non-life - threatening, community-acquired staphylococcal infections which require antibiotics should include erythromycin, cotrimoxazole or diclozacillin (in order of rising cost). ACKNOWLEDGEMENTS Supported in part by a grant F81/84 from the University of Malaya. The authors thank members of the Class 81/85, Faculty of Medicine, University of Malaya and the staff at the district hospital, Banting who helped in the collection of specimens and discussion of the manuscript. REFERENCES Centers for Disease Control. Nosocomial Infection Surveillance 1980-82. COC Surveillance Summaries 1983; 32 : 1SS~16SS. 2 Haley R W, Hightower A W, Khabbaz R F et al. The emergence of methicillin-resistant S. aureus infections in United States' hospitals. Ann Intern Med 1982; 97 : 297-308. Kayser F H. Methicillin-resistant Staphylococcus 1965-75. Lancet.1975; 2 : 650-652. 4 Crosley K, Loesch D. Landesman B. Mead K. Chern M. Strate R_ An outbreak of infection caused by strains of S. aureus resistant to methicillin and aminoglycosides. I. Clinical studies. J Infect Ois 1979; 139 : 273-279. Ross S, Rodriguez W, Controm G, Khan W. Staphylococcal susceptibility to Penicillin G. The changing pattern among community strains. J Am Med Assoc 1974; 229: 1075-1077. 6 Saravolatz L D, Pohlod DJ. Arking L M. Communityacquired methicillin-resistant S. aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982; 97 : 325-329. 7 Levine D P, Cushing R D, Jui J, Brown W J. Community-acquired methicillin-resistant S. aureus endocarditis in the Detroit Medical Center. Ann Intern Med 1982; 97 : 330-338. 8 Reeves D S, Phillips I, Williams J D, Wise R (eds). Laboratory Methods in Antimicrobial Chemotherapy. Edinburgh: Churchill Livingstone. 1978 : 26. 28

9 Hewitt J H, Coe A W, Parker M T. The detection of methicillin resistance in Staphylococcus aureus. J Med Microbiology 1969; 2 : 443-456. 10 Blair J E. Factors determining the pathogenicity of Staphylococci. Ann Rev Micro 1958; 12 : 491-506. 11 Tulloch L G. Nasal carriage in Staphylococcal skin infections. Br Med J 1954; ii : 912-913. 12 Elek S D. Experimental S. aureus infections in the skin of man. Ann NY Acad Sci 1956; 65 : 85-89. 13 Tuazon C U, Sheagren J N. Staphylococcal endocarditis in parenteral drug abusers: sources of organisms. Ann Intern Med 1975; 82 : 788-790. 14 Elek S D. Staphylococcus pyogenes and its relation to disease. Edinburqh: E & S Livingstone, 1959; 153-161. 15 Mortimer E A, Wolinsky E, Gonzaga A J, Rammelkamp C H. Role of airborne transmission in Staphylococcal infection. Br Med J 1966; 1 : 319-322. 16 Lacey R W. Antibiotic resistance plasm ids of S. aureus and their clinical importance. Bacteriol Review 1975; 39 : 1-32. 17 Novick R P, Morse S. In vivo transmission of drug resistance factors between strains of S. aureus. J Exp Med 1967; 125 : 45-59. 18 Jensen 0, Rosendal K, Bulow P, Faber V, Eriksen K R. Changing Staphylococci and Staphylococcal infections. N Eng J Med 1969; 281 : 627-635. 19 Sabath L D. Mechanisms of resistance to beta-iactam antibiotics in strains of S. aureus. Ann Intern Med 1982; 97 : 339-344. 20 Boyce J M, Landry M, Deetz T R, DuPont H L. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant S. aureus infections. Infect Control 1981 ; 2 : 110-11 6. 21 Peacock J E, Marsik J F, Wenzel R P. Methicillinresistant S. aureus; introduction and spread with in a hospital. Ann Intern Med 1980; 93 : 526-532. 22 Peacock J E, Moorman D R, Wenzel R P, Mandell G L. Methicillin-resistant S. aureus: Microbiologic characteristics, antimicrobic susceptibil ities and assessment of virulence of an epidemic strain. J Infect Dis 1981; 144 : 575-582. 23 Mohammad Rohani B Jais. Ujian in vitro aktiviti asid klavulanik, amoxycillin dan augmentin terhadap strain-strain S. aureus yang methicillin-resistan. Report submitted in fulfillment of the requirements for the Diploma in Medical Laboratory Technology, Faculty of Medicine, Universiti Kebangsaan Malaysia 1983. 24 Aly R, Shinefield H R, Maibach H I. S. aureus adherence to nasal epithelial cells: studies of some parameters. In: Mai bach HI, Aly R (eds.) Skin Microbiology: Relevance to Clinical Infections. New York: Springer-Verlag, 1981: 171-179. 25 Locksley R M, Mitchell L C, Thomas C Q et al. Multiple antibiotic-resistant S. aureus: introduction, transmission and evolution of nosocomial infection. Ann Intern Med 1982; 97 : 317-324. 26 Sorrel! T C, Packham D R, Shander S, Foldes M, Munro R. Vancomycin therapy for methicillinresistant S. aureus. Ann Intern Med 1982; 97 : 344 350. 27 Thompson R L, Cabezudo I, Wenzel R P. Epidemiology of nosocomial infections caused by methicillinresistant S. aureus. Ann Intern Med 1982; 97 : 309 317. 28 Bryan C S, Wilson R S, Meade P, Sill L G. Topical antibiotic ointment for staphylococcal nasal carriers: survey of current practices and comparison of bacitracin and vancomycin ointments. Infect Control 1980; 1 : 153-1 56. 29 Wheat L J, Kohler R B, White A L, White A. Effect of rifampin on nasal carriers of coagulase-positive staphylococci. J Infect Dis 1981; 144 : 177. 30 Ward T T, Winn R E, Hartstein A I, Sewell D L. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: role of antim icrobial therapy in infection control. Infect Control 1981; 2 : 453-459. 29